2 ms·
> The very way we all think about disease — and the best ways to research, define, prevent, and treat it — is being subtly distorted because so many of the oste
by umvi 5y ago
> The very way we all think about disease — and the best ways to research, define, prevent, and treat it — is being subtly distorted because so many of the ostensibly independent players, including patient advocacy groups, are largely singing tunes acceptable to companies seeking to maximize markets for drugs and devices
Not just medicine, but a lot of other areas of science. Covid just unveiled how science is in a trust crisis.
- pfisherman 5y agoA degree of collaboration is unsurprising. Pharma companies are THE entities that develop, manufacture, and market drugs. How are you going to develop, manufacture, and market medicines without them? The idea being pushed here is someone’s opinion and a pretty big jump to conclusions from the data in Vinay’s article. My experience, pharma companies play in later stages of development and marketing. The bulk of early stage R&D is done at academic institutions and funded by the NIH. When pharma companies fund academic research they are usually paying for information and ideas. Edit: I should specify that I am talking about preclinical research. For clinical trials they are paying for access to a particular patient population and the ability of the PI / study site to execute. Edit 2: Also device companies are definitely B players compared to pharmaceuticals. Something like 80% of device companies have less than 50 employees, and their market caps are a joke compared to the drug companies with the exception of the very few (Abbott, Medtronic, etc)